R&D and QC in Food sector notably rises in 2015
Health care trends emphasized at China Healthcare Summit
Chinese pharmaceutical companies making numerous foreign acquisitions
China leads in global greenfield FDI
China’s CICs help bridge the gap between science and economy
Last month, the State Council of China released the details of the five-year National Science and Technology Innovation Plan, which is designed to further progress scientific advancements in China. With the goal of continuing and improving China’s global scientific innovation contributions, the Innovation Plan includes but is not limited to: developing projects to further treat […]
Early this month, the Communist Party and the State Council’s Central Committee issued recommendations to permit scientists and researchers to have more control over the allocation of research grants for R&D funding. From 2010 to 2014, China’s total expenditure on R&D grew from CNY 706.3 billion to CNY 1.3 trillion ($211 billion), making up a […]
Sequencing in China is on a rapid rise, with the country accounting for 20%–30% of global sequencing capacity. Driving this growth is China’s 15-year precision medicine program (see IBO 1/31/16). The multi-billion dollar budget of the initiative will be used for improving precision medicine technology, sequencing, analyzing over a million human genomes, and drug development […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
